Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica
NCT01914042 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2019-04-02
Summary
Clinical, psychophysical, behavioral or genetic factor will predict the response to opioid treatment in patients with chronic neuropathic pain.
Conditions
- Neuropathic Pain
Interventions
- DRUG
-
Morphine
- DRUG
-
Milnacipran
Sponsors & Collaborators
-
Rambam Health Care Campus
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2019-07-31
- Completion
- 2019-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Effect of Milnacipran in Chronic Neuropathic Low Back Pain
NCT01225068 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Effect of Motor Cortex Stimulation in Patients Suffering From Chronic Neuropathic Pain
NCT03189823 ·Status: COMPLETED
-
Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy
NCT01564069 ·Status: COMPLETED
-
Effect of Minocycline on Pain Caused by Nerve Damage
NCT01869907 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.
NCT02100046 ·Status: COMPLETED ·Phase: PHASE2
-
Neurotropin to Treat Chronic Neuropathic Pain
NCT00006289 ·Status: TERMINATED ·Phase: PHASE2
-
Discovery and Analytical Validation of Inflammatory Bio-signatures of the Human Pain Experience
NCT05074485 ·Status: RECRUITING ·Phase: PHASE1
-
Molecular Mediators of Nerve Injury Signaling
NCT01437332 ·Status: UNKNOWN
-
Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients
NCT02345291 ·Status: COMPLETED ·Phase: PHASE2
-
A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain
NCT01288937 ·Status: TERMINATED ·Phase: PHASE3
-
Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients
NCT01363284 ·Status: COMPLETED ·Phase: NA
-
Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
NCT05805683 ·Status: RECRUITING ·Phase: NA
-
Frequency of Piriformis Syndrome:Does the Presence of One Pathology Rule Out the Other?
NCT05450913 ·Status: UNKNOWN ·Phase: NA
-
Tariquidar-ondansetron Combination in Neuropathic Pain
NCT04603066 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain
NCT01053845 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain
NCT00181246 ·Status: COMPLETED ·Phase: NA
-
Preferences in Pain Treatment: A Discrete Choice Experiment in Patients With Peripheral Neuropathic Pain (pNP)
NCT04184596 ·Status: COMPLETED
-
Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I
NCT02402530 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects
NCT02116790 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Safety of Intravenous Neridronic Acid in CRPS
NCT03530345 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Mirogabalin for Central Neuropathic Pain
NCT03901352 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)
NCT00837941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Observational Study Aimed at Evaluating the Trend of Neuropathic Pain
NCT06324123 ·Status: COMPLETED
-
A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021
NCT01121380 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain
NCT04431778 ·Status: UNKNOWN ·Phase: PHASE2